Rare eye condition prompts new FDA warning on popular GLP-1 drugs

AI Summary

The U.S. Food and Drug Administration is requiring manufacturers of Ozempic, Wegovy, and similar GLP-1 drugs to warn about a rare eye condition that can cause vision loss. The warning adds a potential serious risk to the prescribing information for these medications.

The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.